SPO Medical launches pulse oximetry system with European language support

7 July 2008

SPO Medical Inc. (SPOM) has released its PulseOx 7500 pulse oximetry system with support for a graphical user interface and report generation in multiple languages, including French, Italian, German and Spanish (FIGS) along with English.

The company believes that by supporting FIGS languages it will be able to address the growing interest in the system across European markets and the Spanish-speaking markets of the Americas.

Sleep apnea is a sleep disorder characterized by pauses in breathing during sleep. Each episode, called apneas, lasts long enough so that one or more breaths are missed, and occurs repeatedly throughout sleep, disturbing a person's sleep pattern.

Symptoms may be present for years, even decades without identification, during which time the sufferer may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Such fatigue is known to be the cause of road accidents, industrial accidents and reduction in performance at the work place.

Typically, people with sleep disorder symptoms are referred by their primary care physician to third-party sleep clinics for overnight monitoring at the clinic facility, and depending on the diagnosis, are prescribed an appropriate medical remedy.

The PulseOx 7500 enables doctors and other medical professionals to monitor patients from the convenience of the patient's home. Data is collected and stored overnight by wearing the PulseOx 7500 wrist-watch configuration while the user sleeps. The next morning, the data is easily downloaded by the family care or general practitioner for analysis using supplied reporting software.

"We are delivering this new product feature as a direct result of increased demand from our European sales distributors. Those caring for sleep apnea sufferers recognize the value proposition of the PulseOx 7500 and our cost-effective product is now available to a wider multi-language community as an effective pre-screening device for detecting sleep disorders in the comfort of a patient's home," commented Michael Braunold, President and CEO of SPO Medical.

To top